Stock & Company Details
Avanos Medical Inc $AVNS
Price:
46,691,331
47M
$1.2B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
-17.08
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
AVNS technical indicators
Latest Avanos Medical Inc (AVNS) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
61.98 6.2%
MACD:
0.19 9.3%
SMA 50:
$24.81 0.0%
SMA 200:
$15.81 0.4%
EMA 20:
$24.87 0.0%
Bollinger Bands:
25.05 / 24.87
Stochastic:
22.97 9.8%
ADX 14:
58.41 1.4%
ATR 14:
0.11 3.3%
CCI 20:
-104.84 39.6%
OBV:
23.97M 1.3%
ROC 12:
-0.40% 100.0%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.
Finance Bot
Ask your questions
Start by typing a question below.
